State Of Wyoming Catalent, Inc. Transaction History

State Of Wyoming

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $6,403 - $13,519	201 Added 26.73%	953 $41,000
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $14,177 - $23,169	312 Added 70.91%	752 $49,000
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $1,324 - $2,592	-32 Reduced 6.78%	440 $19,000
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $10,636 - $16,625	-147 Reduced 23.75%	472 $34,000
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $1,133 - $1,482	-13 Reduced 2.06%	619 $66,000
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $28,068 - $37,098	298 Added 89.22%	632 $70,000
Q4 2021 Feb 11, 2022	SELL	$119.57 - $139.07 $21,881 - $25,449	-183 Reduced 35.4%	334 $43,000
Q3 2021 Feb 11, 2022	SELL	$109.17 - $142.35 $1,091 - $1,423	-10 Reduced 1.9%	517 $69,000
Q2 2021 Feb 11, 2022	BUY	$100.34 - $115.69 $34,717 - $40,028	346 Added 191.16%	527 $57,000
Q1 2021 Feb 08, 2022	BUY	$101.51 - $125.27 $18,373 - $22,673	181 New	181 $19,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.